Akrivis Technologies, LLC, a launched venture of IDEA: Northeastern’s Venture Accelerator, participated in the 2012 MassChallenge accelerator competition. MassChallenge is the largest startup accelerator supporting early-stage entrepreneurs. This year, MassChallenge granted $1 million in cash prizes and more than $10 million in in-kind benefits.
Akrivis placed in the top 26 out of 1,237 applicants. Throughout the four month long program, Akrivis had access to mentorship and training, media opportunities, and other resources to expand their business.
The entire IDEA team congratulates Akrivis on their achievement and wishes them continued success in the future!
About Akrivis Technologies
Akrivis Technologies, LLC is a privately held life sciences company founded in 2009 and committed to the development and commercialization of products and services for the early detection and treatment of serious human diseases. Akrivis’ main asset is its proprietary Z–TECT™ Technology Platform which provides ultra sensitive detection and accurate quantification of biomolecules present in the zeptomole range (10E–21 moles), therefore allowing the detection of less than a thousand individual molecules. In addition to supporting in vitro and in vivo diagnostics, Z–TECT™ can also serve as a novel platform for the targeted delivery of radio– and chemo–therapeutic drugs for cancer treatments. Potentially providing far safer and more efficacious targeted delivery therapeutics, Z–TECT™ could have a major impact on the emerging field of “Theranostics” which combines cancer therapies with companion in vivo imaging diagnostics. Learn more at www.akrivis.com
MassChallenge is the largest-ever startup accelerator and competition, and the first to support high-impact, early-stage entrepreneurs with no strings attached. The competition is open to anyone in the world, with any new startup, in any industry. Every entrant receives training, feedback, PR and networking support via expert volunteers from partner organizations. 125 of the highest-potential startups receive 3+ months of intensive mentorship and other free resources, including office space and targeted introductions to customers and funding sources. The very best startups are identified by expert judges to receive cash awards toward launching their businesses along with enhanced PR and privileged access to top investors seeking to place seed capital to work in high-growth firms. Learn more at www.masschallenge.org